Indeed, in both COPD or control fibroblasts treated with EP2 and EP4 antagonists together (AH6809 and GW627368X or PF-04418948 and L-161,982), PGE2-induced senescence was significantly reduced (Dagouassat et al., 2013). The gene discussed is PTGER2; the disease is chronic obstructive pulmonary disease.